ProShares UltraShort NASDAQ Biotechnology
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
122% more capital invested
Capital invested by funds: $387K [Q2] → $858K (+$471K) [Q3]
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
17% more funds holding
Funds holding: 6 [Q2] → 7 (+1) [Q3]
11.19% more ownership
Funds ownership: 11.61% [Q2] → 22.81% (+11.19%) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for BIS.
Financial journalist opinion
Charts implemented using Lightweight Charts™